Evaluation of Outcome In Patients Suffering from COVID-19 Infection – A Retrospective Study

##plugins.themes.academic_pro.article.main##

Tanveer Singh
Navjot Singh Dahiya
Angad Singh Johal
Jasmine Kaur

Abstract

Background: Severe Acute Respiratory syndrome Coronavirus–2 (SARS –Cov-2) named COVID-19 (Coronavirus Disease – 2019) pandemic is the biggest public health problem the human mankind is facing today. Objective: Primary objective was to determine in-hospital mortality within 30 days of admission. The secondary objective was to analyze the risk factors leading to deterioration and poor outcome in patients suffering from COVID-19 infections. Material and Methods: This Multicentric, Retrospective Observational cohort study was conducted in confirmed COVID-19 infected patients admitted in three COVID care centers of Jalandhar city during January 2020 to June 2021. The data of admitted Patients was retrospectively analyzed. The study has been approved by Institutional Ethics Committee of Punjab Institute of Medical Sciences, Jalandhar reference number PIMS/IEC/22/10. Results: Total 1139 patients were admitted in three COVID centers of the city during the period of January 2020 to June 2021. The mean age of the patients was 54.96 ±15.43, 706 (62%) were male and 433 (38%) were female, 523 (45.9%) belong to rural area and 616 (54.1%) belong to urban area. 580 (50.9%) have comorbid condition while 559 (49.1%) do not have any comorbidity. The total number of deaths reported was 225 (19.8%). Comorbidities were seen in 580 patients (50.9%) with 126 deaths (21.7%). Out of 1139, 336(29.5%), 211(18.5%), 31(2.7%), 2(0.2%) had one, two, three and four number of comorbidities respectively. The maximum number of deaths i.e. 140 deaths (12.3%) were seen in the age group of 51–75. Conclusion: Maximum mortality rate was seen in the age group of 50-75 years of age, with significant number of deaths in rural population with two comorbidities in patients suffering from Diabetes and hypertension.

##plugins.themes.academic_pro.article.details##

How to Cite
Singh, T., Dahiya, N. S., Johal, A. S., & Kaur, J. (2022). Evaluation of Outcome In Patients Suffering from COVID-19 Infection – A Retrospective Study. International Journal of Medical and Dental Sciences, 11(2), 2040–2045. https://doi.org/10.18311/ijmds/2022/583

References

  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: The mystery and the miracle. J Med Virol. 2020; 92:401-402. https://doi.org/10.1002/jmv.25678. PMid:31950516. PMCid:PMC7166 628
  2. Hui DS, Azhar I, Madani TA, et al. The continuing 2019nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 2020(91):264-6. https://doi.org/10.1016/j.ijid.2020.01.009. PMid:31953166. PMCid:PMC7128332
  3. Wuhan Municipal Health Commission. Report of novel coronavirus-infected pneumonia in China; 2020.
  4. Hu B, Zeng L-P, Yang X-L, Ge X-Y, Zhang W, Li B et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog. 2017; 13. https://doi.org/10.1371/journal.ppat.1006698 PMid:29190287 PMCid: PMC5708621
  5. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). World Health Organization (WHO) (Press release); 2020.
  6. WHO Director-General’s opening remarks at the media briefing on COVID-19, 11 March 2020. World Health Organization (WHO) (Press release); 2020.
  7. Available from: Ourworldindata.org/coronavirus.
  8. Available from: https://www.COVID19india.org/
  9. Clinical Management Protocol Algorithm Adults. Available from: https://www.mohfw.gov.in/pdf/COVID19
  10. Available from: https://www.mohfw.gov.in/pdf/UpdatedDetailedClinicalManagementProtocolforCOVID19adultsdated24052021.pdf
  11. Biccard B, et al. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study. Lancet 2021; 397:1885-94. https://doi.org/10.1016/S0140-6736(21)00441-4
  12. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395:1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
  13. Lanham D, Roe AJ, Chauhan BA, Evans CR, Hillman CT, Logan EDS, Heightman M. COVID-19 emergency department discharges: an outcome study. Clin Med. 2021; 21(2):e126-e131. https://doi.org/10.7861/clinmed.2020-0817. PMid:33419864. PMCid:PMC8002789
  14. Boari GEM, Chiarini G, Bonetti S, Malerba P, Bianco G, Faustini C, Braglia-Orlandini F. Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: A retrospective cohort study. Biosci Rep. 2020; 40(12). https://doi.org/10.1042/BSR20203455. PMid:33201172. PMCid:PMC7724688
  15. de Souza R, Mhatre S, Qayyumi S, et al. Clinical course and outcome of patients with COVID-19 in Mumbai City: An observational study. BMJ Open. 2021. https:// doi.org/10.1136/bmjopen-2020-042943. PMid:33958335. PMCid:PMC8103559
  16. Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study. The Lancet. 2020; 395:1763-70. https://doi.org/10.1016/S0140-6736(20)31189-2
  17. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323:2052-2059. https://doi.org/10.1001/jama.2020.6775. PMid:32320003. PMCid:PMC7177629